oncgnostics GmbH
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.
oncgnostics GmbH is working according to ISO 13485 standards in research, development, production and management.
Recent Posts
Contact
oncgnostics GmbH
Löbstedter Str. 41
07749 Jena
Germany
Phone: +49 (0)3641 5548500
Email: contact[at]oncgnostics.com
Internet: www.oncgnostics.com
Study „OroCa-Graz“ – Study on Head-and-Neck tumors: oncgnostics GmbH cooperates with the Medical University of Graz
Press ReleasesThe biotechnology company oncgnostics GmbH is researching a method for diagnosing Head-and-Neck tumors together with the clinical department for general ENT at the Medical University of Graz as part of […]
International sales partnership with EUROIMMUN for Distribution of GynTect
Press ReleasesBiotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a PerkinElmer company. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from […]
PCR: Certainty in the shortest possible time
BlogThe method of the PCR stands for the polymerase chain reaction. The underlying process has fundamentally changed medical and biotechnological research. It is now considered the most important laboratory method […]
Looking back on a successful year of research
Blog2020 was a challenging year – also for our company. Nevertheless, we look back on successful achievements. GynTect® convinces in test comparison In November, the journal Clinical Epigenetics published a […]
HPV Vaccination: Help against various Types of Cancer
BlogThe World Health Organization (WHO) sees an increasing HPV vaccination worldwide as a great opportunity in the fight against various types of cancer. At the organization’s annual meeting, WHO director […]
The Uterus – A Complex Organ
BlogAlmost half of mankind owns this organ and every human life starts in it: the uterus. At the latest, with the first menstruation every woman becomes aware of her own […]
On the World Mental Health Day
Press ReleasesAbnormal results in Cervical Cancer Screening may trigger symptoms of post-traumatic stress disorder. Oncgnostics GmbH draws attention to this on the annual World Mental Health Day on 10 October and […]
Cancer screening: Suddenly, it has an effect on family planning
Press ReleasesExperience reports from women who are in family planning, but for whom a conspicuous finding was made during cancer screening, are often characterised by uncertainty and frustration. After a joint […]
Cervical cancer screening in Cuba
BlogDuring the first days of March, Dr. Alfred Hansel took a close look at the healthcare system of Cuba. The Managing Director of oncgnostics GmbH participated in the Cuban-German Healthtech […]
Human papillomaviruses (HPV) – What is it?
BlogHuman papillomaviruses are a group of widespread viruses. In most cases, people affected by the virus are unaware of the infection. However, certain types of HPV are responsible for the […]